Skip to main content
Erschienen in: World Journal of Surgery 9/2007

01.09.2007

Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy

verfasst von: Li Zhou, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu, Tian-Yi Chi, Xue Wei, Kai Han, Ning Zhang, Hai-Tao Zhao

Erschienen in: World Journal of Surgery | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Radical major hepatectomy (RMH) has been suggested as one of main options for cure of large/advanced hepatocellular carcinoma (HCC). However, its operative risk remains high and its effectiveness is still controversial, especially for patients with liver cirrhosis. The present study aims to investigate short- and long-term outcomes and to identify prognostic factors for cirrhotic patients with HCC after RMH.

Materials and Methods

Prospectively collected clinicopathological data of 81consecutive cirrhotic HCC patients who underwent RMH were reviewed retrospectively. The Kaplan-Meier method was adopted for evaluating long-term survival. Prognostic factors were identified by univariate and multivariate analyses.

Results

After RMH, perioperative mortality, overall morbidity, and life-threatening morbidity were 1.2%, 24.7%, and 12.3%, respectively. Overall and disease-free 5-year survival rates were 39.4% and 28.1%, respectively. Univariate analysis showed that presence of portal vein tumor thrombosis (PVTT) and satellite nodules, late TNM staging, high Edmondson-Steiner grading, and blood transfusion was associated with worsened prognosis. Of them, Edmondson-Steiner grading was identified as the sole independent prognostic factor for both overall and disease-free survival by multivariate analysis, whereas blood transfusion and the presence of PVTT independently predicted unfavorable overall or disease-free survival, respectively.

Conclusions

These data indicated that RMH was safe and appeared to be effective in treating cirrhotic patients with HCC. Some tumor-related and clinical variables influenced long-term outcome of these patients after RMH.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, et al. (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156PubMedCrossRef Parkin DM, Bray F, Ferlay J, et al. (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156PubMedCrossRef
2.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, et al. (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63–70PubMedCrossRef Poon RT, Fan ST, Lo CM, et al. (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63–70PubMedCrossRef
3.
Zurück zum Zitat Shimozawa N, Hanazaki K (2004) Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 198:356–365PubMedCrossRef Shimozawa N, Hanazaki K (2004) Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 198:356–365PubMedCrossRef
4.
Zurück zum Zitat Lau WY, Ho SK, Yu SC, et al. (2004) Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 240:299–305PubMedCrossRef Lau WY, Ho SK, Yu SC, et al. (2004) Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 240:299–305PubMedCrossRef
5.
Zurück zum Zitat Kianmanesh R, Regimbeau JM, et al. (2003) Selective approach to major hepatic resection for hepatocellular carcinoma in chronic liver disease. Surg Oncol Clin North Am 12:51–63CrossRef Kianmanesh R, Regimbeau JM, et al. (2003) Selective approach to major hepatic resection for hepatocellular carcinoma in chronic liver disease. Surg Oncol Clin North Am 12:51–63CrossRef
6.
Zurück zum Zitat Lang BH, Poon RT, Fan ST, et al. (2003) Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 138:1207–1213PubMedCrossRef Lang BH, Poon RT, Fan ST, et al. (2003) Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 138:1207–1213PubMedCrossRef
7.
Zurück zum Zitat Shimada M, Gion T, Hamatsu T, et al. (1999) Evaluation of major hepatic resection for small hepatocellular carcinoma. Hepatogastroenterology 46:401–406PubMed Shimada M, Gion T, Hamatsu T, et al. (1999) Evaluation of major hepatic resection for small hepatocellular carcinoma. Hepatogastroenterology 46:401–406PubMed
8.
Zurück zum Zitat Couinaud C (1999) Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 16:459–467PubMedCrossRef Couinaud C (1999) Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 16:459–467PubMedCrossRef
9.
Zurück zum Zitat Capussotti L, Muratore A, Massucco P, et al. (2004) Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes. Liver Transpl 10(suppl 1):S64–S68PubMedCrossRef Capussotti L, Muratore A, Massucco P, et al. (2004) Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes. Liver Transpl 10(suppl 1):S64–S68PubMedCrossRef
10.
Zurück zum Zitat Nagasue N, Yamanoi A, el-Assal ON, et al. (1999) Major compared with limited hepatic resection for hepatocellular carcinoma without underlying cirrhosis: a retrospective analysis. Eur J Surg 165:638–646PubMedCrossRef Nagasue N, Yamanoi A, el-Assal ON, et al. (1999) Major compared with limited hepatic resection for hepatocellular carcinoma without underlying cirrhosis: a retrospective analysis. Eur J Surg 165:638–646PubMedCrossRef
11.
Zurück zum Zitat Chan SC, Liu CL, Lo CM, et al. (2003) Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma. Arch Surg 138:265–271PubMedCrossRef Chan SC, Liu CL, Lo CM, et al. (2003) Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma. Arch Surg 138:265–271PubMedCrossRef
12.
Zurück zum Zitat Zhou L, Rui JA, Wang SB, et al. (2003) Multi-modal serial therapy for primary liver cancer in senile patients: a report of 153 cases. Zhonghua Zhong Liu Za Zhi 25:404–406PubMed Zhou L, Rui JA, Wang SB, et al. (2003) Multi-modal serial therapy for primary liver cancer in senile patients: a report of 153 cases. Zhonghua Zhong Liu Za Zhi 25:404–406PubMed
13.
Zurück zum Zitat Qu Q, Rui JA, Wang SB, et al. (2006) Comparison of different clinical staging systems for hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 28:155–158PubMed Qu Q, Rui JA, Wang SB, et al. (2006) Comparison of different clinical staging systems for hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 28:155–158PubMed
14.
Zurück zum Zitat Zhou L, Rui JA, Wang SB, et al. (2006) Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 32:767–772PubMedCrossRef Zhou L, Rui JA, Wang SB, et al. (2006) Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 32:767–772PubMedCrossRef
15.
Zurück zum Zitat Terminology Committee of the International Hepato-Pancreato-Biliary Association (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2:333–339 Terminology Committee of the International Hepato-Pancreato-Biliary Association (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2:333–339
16.
Zurück zum Zitat Hermanek P, Sobin LH (1992) TNM Classification of Malignant Tumors. Berlin, Springer-Verlag, 104–112 Hermanek P, Sobin LH (1992) TNM Classification of Malignant Tumors. Berlin, Springer-Verlag, 104–112
17.
Zurück zum Zitat Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503PubMedCrossRef Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503PubMedCrossRef
18.
Zurück zum Zitat Thompson HH, Tompkins RK, Longmire WP Jr. (1983) Major hepatic resection. A 25-year experience. Ann Surg 197:375–388PubMedCrossRef Thompson HH, Tompkins RK, Longmire WP Jr. (1983) Major hepatic resection. A 25-year experience. Ann Surg 197:375–388PubMedCrossRef
19.
Zurück zum Zitat Tjandra JJ, Fan ST, Wong J (1991) Peri-operative mortality in hepatic resection. Aust N Z J Surg 61:201–206PubMed Tjandra JJ, Fan ST, Wong J (1991) Peri-operative mortality in hepatic resection. Aust N Z J Surg 61:201–206PubMed
20.
Zurück zum Zitat Pol B, Campan P, Hardwigsen J, et al. (1999) Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg 165:446–453PubMedCrossRef Pol B, Campan P, Hardwigsen J, et al. (1999) Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg 165:446–453PubMedCrossRef
21.
Zurück zum Zitat Chang YC (2004) Low mortality major hepatectomy. Hepatogastroenterology 51:1766–1770PubMed Chang YC (2004) Low mortality major hepatectomy. Hepatogastroenterology 51:1766–1770PubMed
22.
Zurück zum Zitat Man K, Lo CM, Liu CL, et al. (2003) Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg 90:183–189PubMedCrossRef Man K, Lo CM, Liu CL, et al. (2003) Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg 90:183–189PubMedCrossRef
23.
Zurück zum Zitat Belghiti J, Noun R, Malafosse R, et al. (1999) Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 229:369–375PubMedCrossRef Belghiti J, Noun R, Malafosse R, et al. (1999) Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 229:369–375PubMedCrossRef
24.
Zurück zum Zitat Capussotti L, Nuzzo G, Polastri R, et al. (2003) Continuous versus intermittent portal triad clamping during hepatectomy in cirrhosis. Results of a prospective, randomized clinical trial. Hepatogastroenterology 50:1073–1077PubMed Capussotti L, Nuzzo G, Polastri R, et al. (2003) Continuous versus intermittent portal triad clamping during hepatectomy in cirrhosis. Results of a prospective, randomized clinical trial. Hepatogastroenterology 50:1073–1077PubMed
25.
Zurück zum Zitat Fan ST, Lai EC, Lo CM, et al. (1996) Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg 83:117–120PubMedCrossRef Fan ST, Lai EC, Lo CM, et al. (1996) Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg 83:117–120PubMedCrossRef
26.
Zurück zum Zitat Hodgson WJ, Morgan J, Byrne D, et al. (1992) Hepatic resections for primary and metastatic tumors using the ultrasonic surgical dissector. Am J Surg 163:246–250PubMedCrossRef Hodgson WJ, Morgan J, Byrne D, et al. (1992) Hepatic resections for primary and metastatic tumors using the ultrasonic surgical dissector. Am J Surg 163:246–250PubMedCrossRef
27.
Zurück zum Zitat Azoulay D, Castaing D, Krissat J, et al. (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232:665–672PubMedCrossRef Azoulay D, Castaing D, Krissat J, et al. (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232:665–672PubMedCrossRef
28.
Zurück zum Zitat Wakabayashi H, Ishimura K, Okano K, et al. (2001) Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer 92:2384–2390PubMedCrossRef Wakabayashi H, Ishimura K, Okano K, et al. (2001) Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer 92:2384–2390PubMedCrossRef
29.
Zurück zum Zitat Fukuda S, Itamoto T, Nakahara H, et al. (2005) Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 52:1163–1167PubMed Fukuda S, Itamoto T, Nakahara H, et al. (2005) Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 52:1163–1167PubMed
30.
Zurück zum Zitat Ker CG, Chen HY, Chen KS, et al. (2003) Clinical significance of cell differentiation in hepatocellular carcinoma. Hepatogastroenterology 50:475–479PubMed Ker CG, Chen HY, Chen KS, et al. (2003) Clinical significance of cell differentiation in hepatocellular carcinoma. Hepatogastroenterology 50:475–479PubMed
31.
Zurück zum Zitat Park JH, Koh KC, Choi MS, et al. (2006) Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg 192:29–33PubMedCrossRef Park JH, Koh KC, Choi MS, et al. (2006) Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg 192:29–33PubMedCrossRef
32.
Zurück zum Zitat Makino Y, Yamanoi A, Kimoto T, et al. (2000) The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 95:1294–1300PubMedCrossRef Makino Y, Yamanoi A, Kimoto T, et al. (2000) The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 95:1294–1300PubMedCrossRef
33.
Zurück zum Zitat Hanazaki K, Kajikawa S, Shimozawa N, et al. (2005) Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 52:524–529PubMed Hanazaki K, Kajikawa S, Shimozawa N, et al. (2005) Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 52:524–529PubMed
34.
Zurück zum Zitat Kwon AH, Matsui Y, Kamiyama Y (2001) Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 91:771–778PubMedCrossRef Kwon AH, Matsui Y, Kamiyama Y (2001) Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 91:771–778PubMedCrossRef
35.
Zurück zum Zitat Huang YH, Chen CH, Chang TT, et al. (2005) Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 20:765–771PubMedCrossRef Huang YH, Chen CH, Chang TT, et al. (2005) Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 20:765–771PubMedCrossRef
Metadaten
Titel
Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy
verfasst von
Li Zhou
Jing-An Rui
Shao-Bin Wang
Shu-Guang Chen
Qiang Qu
Tian-Yi Chi
Xue Wei
Kai Han
Ning Zhang
Hai-Tao Zhao
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 9/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9029-z

Weitere Artikel der Ausgabe 9/2007

World Journal of Surgery 9/2007 Zur Ausgabe

Invited Commentary

Invited Commentary

Letter to the Editor

Letter to the Editor

Letter

Reply

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.